Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 16, Number 7—July 2010
Dispatch

Detection of Lassa Virus, Mali

David Safronetz, Job E. Lopez, Nafomon Sogoba, Sékou F. Traore’, Sandra J. Raffel, Elizabeth R. Fischer, Hideki Ebihara, Luis M. Branco, Robert F. Garry, Tom G. Schwan, and Heinz FeldmannComments to Author 
Author affiliations: National Institutes of Health, Hamilton, Montana, USA (D. Safronetz, J.E. Lopez, S.J. Raffel, E.R. Fischer, H. Ebihara, T.G. Schwan, H. Feldmann); University of Bamako, Bamako, Mali (N. Sogoba, S.F. Traore’); Tulane School of Medicine, New Orleans, Louisiana, USA (L. Branco, R.F. Garry); Autoimmune Technologies LLC, New Orleans (L. Branco)

Main Article

Appendix Figure

A) Confirmation of isolation of Lassa virus (LASV) Soromba-R by using immunoblot analysis of cell pellets and supernatant from LASV Soromba-R-infected Vero E6 cells (lanes 1 and 3) or uninfected controls (lanes 2 and 4) with a LASV nucleoprotein-specific monoclonal antibody. B) Electron micrograph of LASV particles

Appendix Figure. A) Confirmation of isolation of Lassa virus (LASV) Soromba-R by using immunoblot analysis of cell pellets and supernatant from LASV Soromba-R-infected Vero E6 cells (lanes 1 and 3) or uninfected controls (lanes 2 and 4) with a LASV nucleoprotein-specific monoclonal antibody. B) Electron micrograph of LASV particles

Main Article

Page created: March 02, 2011
Page updated: March 02, 2011
Page reviewed: March 02, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external